These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 26188076)
1. The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator. Richard AC; Ferdinand JR; Meylan F; Hayes ET; Gabay O; Siegel RM J Leukoc Biol; 2015 Sep; 98(3):333-45. PubMed ID: 26188076 [TBL] [Abstract][Full Text] [Related]
2. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Meylan F; Richard AC; Siegel RM Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439 [TBL] [Abstract][Full Text] [Related]
3. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation. Siakavellas SI; Bamias G Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067 [TBL] [Abstract][Full Text] [Related]
4. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. Ferdinand JR; Richard AC; Meylan F; Al-Shamkhani A; Siegel RM J Immunol; 2018 Feb; 200(4):1360-1369. PubMed ID: 29335258 [TBL] [Abstract][Full Text] [Related]
5. The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases. Siakavellas SI; Sfikakis PP; Bamias G Semin Arthritis Rheum; 2015 Aug; 45(1):1-8. PubMed ID: 25887448 [TBL] [Abstract][Full Text] [Related]
6. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity. Valatas V; Kolios G; Bamias G Front Immunol; 2019; 10():583. PubMed ID: 30972074 [TBL] [Abstract][Full Text] [Related]
7. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931 [TBL] [Abstract][Full Text] [Related]
8. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Meylan F; Davidson TS; Kahle E; Kinder M; Acharya K; Jankovic D; Bundoc V; Hodges M; Shevach EM; Keane-Myers A; Wang EC; Siegel RM Immunity; 2008 Jul; 29(1):79-89. PubMed ID: 18571443 [TBL] [Abstract][Full Text] [Related]
9. Directed evolution of a soluble human DR3 receptor for the inhibition of TL1A induced cytokine secretion. Levin I; Zaretsky M; Aharoni A PLoS One; 2017; 12(3):e0173460. PubMed ID: 28278297 [TBL] [Abstract][Full Text] [Related]
11. Soluble TL1A is sufficient for activation of death receptor 3. Bittner S; Knoll G; Füllsack S; Kurz M; Wajant H; Ehrenschwender M FEBS J; 2016 Jan; 283(2):323-36. PubMed ID: 26509650 [TBL] [Abstract][Full Text] [Related]
12. The role of TL1A and DR3 in autoimmune and inflammatory diseases. Aiba Y; Nakamura M Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414 [TBL] [Abstract][Full Text] [Related]
13. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692 [TBL] [Abstract][Full Text] [Related]
14. The TNF-family cytokine TL1A inhibits proliferation of human activated B cells. Cavallini C; Lovato O; Bertolaso A; Pacelli L; Zoratti E; Zanolin E; Krampera M; Zamò A; Tecchio C; Cassatella MA; Pizzolo G; Scupoli MT PLoS One; 2013; 8(4):e60136. PubMed ID: 23565196 [TBL] [Abstract][Full Text] [Related]
15. CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss. Collins FL; Williams JO; Bloom AC; Singh RK; Jordan L; Stone MD; McCabe LR; Wang ECY; Williams AS Bone; 2017 Apr; 97():94-104. PubMed ID: 28062298 [TBL] [Abstract][Full Text] [Related]
16. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease. Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS Front Immunol; 2019; 10():1624. PubMed ID: 31379829 [TBL] [Abstract][Full Text] [Related]
17. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis. Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020 [TBL] [Abstract][Full Text] [Related]
18. TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses. Wang X; Hu Y; Charpentier T; Lamarre A; Qi S; Wu J; Luo H J Immunol; 2013 Dec; 191(11):5420-9. PubMed ID: 24140642 [TBL] [Abstract][Full Text] [Related]
19. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma. Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596 [No Abstract] [Full Text] [Related]
20. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. Pappu BP; Borodovsky A; Zheng TS; Yang X; Wu P; Dong X; Weng S; Browning B; Scott ML; Ma L; Su L; Tian Q; Schneider P; Flavell RA; Dong C; Burkly LC J Exp Med; 2008 May; 205(5):1049-62. PubMed ID: 18411337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]